Published in Pneumologie on June 01, 2006
Efficacy and safety of once-daily NVA237 in patients with moderate-to-severe COPD: the GLOW1 trial. Respir Res (2011) 1.89
Tiotropium for stable chronic obstructive pulmonary disease: A meta-analysis. Thorax (2006) 1.76
Relationship between FEV1 change and patient-reported outcomes in randomised trials of inhaled bronchodilators for stable COPD: a systematic review. Respir Res (2011) 1.51
Inhaled drugs to reduce exacerbations in patients with chronic obstructive pulmonary disease: a network meta-analysis. BMC Med (2009) 1.37
Tiotropium HandiHaler in the treatment of COPD: a safety review. Int J Chron Obstruct Pulmon Dis (2009) 1.32
Pharmacotherapies for chronic obstructive pulmonary disease: a multiple treatment comparison meta-analysis. Clin Epidemiol (2011) 1.21
Efficacy and safety of tiotropium in COPD patients in primary care--the SPiRiva Usual CarE (SPRUCE) study. Respir Res (2007) 1.08
Tiotropium HandiHaler(®) and Respimat(®) in COPD: a pooled safety analysis. Int J Chron Obstruct Pulmon Dis (2015) 0.99
Role of tiotropium in the treatment of COPD. Int J Chron Obstruct Pulmon Dis (2007) 0.99
Comorbidities of patients in tiotropium clinical trials: comparison with observational studies of patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2015) 0.97
Changing patterns in long-acting bronchodilator trials in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2011) 0.93
Clinical trial design in chronic obstructive pulmonary disease: current perspectives and considerations with regard to blinding of tiotropium. Respir Res (2012) 0.87
Study design considerations in a large COPD trial comparing effects of tiotropium with salmeterol on exacerbations. Int J Chron Obstruct Pulmon Dis (2009) 0.84
Preventing and managing exacerbations in COPD--critical appraisal of the role of tiotropium. Int J Chron Obstruct Pulmon Dis (2010) 0.78
Tiotropium formulations and safety: a network meta-analysis. Ther Adv Drug Saf (2016) 0.75
Long-term outcomes in chronic obstructive pulmonary disease patients: exploring the effects of inhalatory devices and their influence on the outcome. Clinicoecon Outcomes Res (2016) 0.75
Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J (2004) 3.19
[German guideline for diagnosis and management of idiopathic pulmonary fibrosis]. Pneumologie (2013) 3.03
The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics. Eur Respir J (2001) 2.77
Reversibility of venous sinus obstruction in idiopathic intracranial hypertension. AJNR Am J Neuroradiol (2007) 1.99
Sputum matrix metalloproteinase-9, tissue inhibitor of metalloprotinease-1, and their molar ratio in patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and healthy subjects. Respir Med (2003) 1.97
Systemic deficiency of glutathione in cystic fibrosis. J Appl Physiol (1985) (1993) 1.88
Nasal CPAP therapy: effects of different CPAP levels on pressure transmission into the trachea and pulmonary oxygen transfer. Acta Anaesthesiol Scand (2002) 1.76
Handle with care: targeting neutrophils in chronic obstructive pulmonary disease and severe asthma? Clin Exp Allergy (2006) 1.64
Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations. Int J Clin Pract (2007) 1.64
The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma. Allergy (2005) 1.51
Augmentation of functional prostaglandin E levels on the respiratory epithelial surface by aerosol administration of prostaglandin E. Am Rev Respir Dis (1991) 1.49
Thrombospondin-related adhesive protein (TRAP) of Plasmodium falciparum: expression during sporozoite ontogeny and binding to human hepatocytes. EMBO J (1995) 1.49
The effect of oral N-acetylcysteine on lung glutathione levels in idiopathic pulmonary fibrosis. Eur Respir J (1994) 1.42
[Combination of asthma and COPD: more frequent as considered to be?]. Pneumologie (2006) 1.40
[Guideline-adherent treatment for asthma]. Internist (Berl) (2008) 1.40
[beta(2)-Sympathomimetics: risks for asthma therapy? Lessons from the SMART1 Study. A statement from the German Respiratory Tract League]. Dtsch Med Wochenschr (2007) 1.39
[Efficacy of a disease management programme in asthma]. Pneumologie (2005) 1.39
Safety and tolerability of omalizumab. Clin Exp Allergy (2009) 1.26
[Guidelines for the diagnosis and therapy of COPD issued by Deutsche Atemwegsliga and Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin]. Pneumologie (2007) 1.23
Effect of internal thoracic artery preparation on blood loss, lung function, and pain. Ann Thorac Surg (1999) 1.18
Elevation of total serum immunoglobulin E is associated with asthma in nonallergic individuals. Eur Respir J (2000) 1.17
Improved asthma control with budesonide/formoterol in a single inhaler, compared with budesonide alone. Eur Respir J (2001) 1.16
Mast cell-derived tumour necrosis factor is essential for allergic airway disease. Eur Respir J (2007) 1.16
Multidisciplinary interobserver agreement in the diagnosis of idiopathic pulmonary fibrosis. Eur Respir J (2007) 1.13
Malignant peripheral nerve sheath tumours--report of 8 cases and review of the literature. Acta Neurochir (Wien) (2001) 1.13
Spontaneous intracranial haematomas caused by neoplasms. Acta Neurochir (Wien) (2000) 1.12
["A small piece of normal life". A qualitative study on health care for chronically ill children in home care]. Pflege (1999) 1.11
Newly diagnosed chronic obstructive pulmonary disease. Clinical features and distribution of the novel stages of the Global Initiative for Obstructive Lung Disease. Respiration (2003) 1.10
Omalizumab in patients with severe persistent allergic asthma in a real-life setting in Germany. Respir Med (2009) 1.09
Authors' response to Walker et al. Thorax (2013) 1.09
Effect of glutathione aerosol on oxidant-antioxidant imbalance in idiopathic pulmonary fibrosis. Lancet (1991) 1.07
Organ specific cytokine therapy. Local activation of mononuclear phagocytes by delivery of an aerosol of recombinant interferon-gamma to the human lung. J Clin Invest (1991) 1.06
Adenovirus-mediated wild-type p53 gene transfer in patients receiving chemotherapy for advanced non-small-cell lung cancer: results of a multicenter phase II study. J Clin Oncol (2001) 1.04
Long-term treatment of alpha1-antitrypsin deficiency-related pulmonary emphysema with human alpha1-antitrypsin. Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL)-alpha1-AT-study group. Eur Respir J (1998) 1.03
Recombinant secretory leukoprotease inhibitor augments glutathione levels in lung epithelial lining fluid. J Appl Physiol (1985) (1993) 1.02
Improvements with tiotropium in COPD patients with concomitant asthma. Respir Med (2007) 1.01
Aerosolization of recombinant SLPI to augment antineutrophil elastase protection of pulmonary epithelium. J Appl Physiol (1985) (1990) 1.00
Stroke pattern interpretation: the variability of hypertensive versus amyloid angiopathy hemorrhage. Cerebrovasc Dis (2001) 0.98
Glutathione in induced sputum of healthy individuals and patients with asthma. Thorax (2001) 0.97
Measuring asthma control: a comparison of three classification systems. Eur Respir J (2010) 0.96
Intravenous N-acetylcysteine and lung glutathione of patients with pulmonary fibrosis and normals. Am J Respir Crit Care Med (1995) 0.96
Oral supplementation with whey proteins increases plasma glutathione levels of HIV-infected patients. Eur J Clin Invest (2001) 0.96
Glutathione deficiency of the lower respiratory tract in patients with idiopathic pulmonary fibrosis. Eur Respir J (2002) 0.95
Sputum levels of metalloproteinase-9 and tissue inhibitor of metalloproteinase-1, and their ratio correlate with airway obstruction in lung transplant recipients: relation to tumor necrosis factor-alpha and interleukin-10. J Heart Lung Transplant (2001) 0.93
Surgical treatment of septic deep venous thrombosis. Surgery (1995) 0.93
Assessment of patient performance of the HandiHaler compared with the metered dose inhaler four weeks after instruction. Respir Med (2003) 0.93
Glutathione aerosol suppresses lung epithelial surface inflammatory cell-derived oxidants in cystic fibrosis. J Appl Physiol (1985) (1999) 0.93
Study of clinical features of amyloid angiopathy hemorrhage and hypertensive intracerebral hemorrhage. J Zhejiang Univ Sci (2004) 0.93
Recommendations for management of equine athletes with cardiovascular abnormalities. J Vet Intern Med (2014) 0.92
Effects of long-term supplementation with whey proteins on plasma glutathione levels of HIV-infected patients. Eur J Nutr (2002) 0.90
[Guidelines for the diagnosis and treatment chronic obstructive bronchitis and pulmonary emphysema issued by Deutsche Atemwegsliga and Deutsche Gesellschaft für pneumologie]. Pneumologie (2002) 0.90
Effect of different asthma treatments on risk of cold-related exacerbations. Eur Respir J (2011) 0.89
Budesonide/formoterol for maintenance and reliever therapy in the management of moderate to severe asthma. Allergy (2008) 0.88
Unusual locations for cavernous hemangiomas: report of two cases and review of the literature. Acta Neurochir (Wien) (2005) 0.88
Registration of functional and anatomical MRI: accuracy assessment and application in navigated neurosurgery. Comput Aided Surg (2000) 0.87
A single nasal allergen challenge increases induced sputum inflammatory markers in non-asthmatic subjects with seasonal allergic rhinitis: correlation with plasma interleukin-5. Clin Exp Allergy (2003) 0.87
Glutathione and glutathione peroxidase in sputum samples of adult patients with cystic fibrosis. J Cyst Fibros (2004) 0.86
Omalizumab reduces oral corticosteroid use in patients with severe allergic asthma: real-life data. Respir Med (2010) 0.86
c-erbB-2 expression in small-cell lung cancer is associated with poor prognosis. Int J Cancer (2001) 0.86
Stability of glutathione in induced sputum: impact of freezing. Respiration (2003) 0.86
The effects of prostacyclin on gastric intramucosal pH in patients with septic shock. Intensive Care Med (1995) 0.85
Indoor air pollutants stimulate interleukin-8-specific mRNA expression and protein secretion of alveolar macrophages. Lung (1999) 0.85
Soot-exposed mononuclear cells increase inflammatory cytokine mRNA expression and protein secretion in cocultured bronchial epithelial cells. Respiration (2000) 0.84
Lymphocyte transformation test in a group of foundry workers exposed to beryllium and non-exposed controls. Eur J Respir Dis Suppl (1986) 0.84
Tumor necrosis factor-alpha modulates the selective interference of hypnotics and sedatives to suppress N-formyl-methionyl-leucyl-phenylalanine-induced oxidative burst formation in neutrophils. Crit Care Med (1997) 0.84
Clinical outcome after surgery of intracranial unruptured aneurysms: results of a series between 1991 and 2001. Acta Neurochir Suppl (2002) 0.83
Kalanchoe pinnata inhibits mast cell activation and prevents allergic airway disease. Phytomedicine (2011) 0.83
Short-term effects of regular salmeterol treatment on adult cystic fibrosis patients. Eur Respir J (1997) 0.83
Prevalence of exercise-associated arrhythmias in normal performing dressage horses. Equine Vet J Suppl (2010) 0.83
Jugular venous pooling during lowering of the head affects blood pressure of the anesthetized giraffe. Am J Physiol Regul Integr Comp Physiol (2009) 0.83
Glutathione in spermatozoa and seminal plasma of infertile men. Hum Reprod (1998) 0.82
Comparative loss of activity of recombinant secretory leukoprotease inhibitor and alpha 1-protease inhibitor caused by different forms of oxidative stress. Eur Respir J (1997) 0.82
Antiinflammatory properties of ambroxol. Eur J Med Res (2008) 0.81
Effect of the oral leukotriene B4 receptor antagonist LTB019 on inflammatory sputum markers in patients with chronic obstructive pulmonary disease. Pulm Pharmacol Ther (2007) 0.81
Use of secretory leukoprotease inhibitor to augment lung antineutrophil elastase activity. Chest (1996) 0.81
Controlled and uncontrolled allergic asthma in routine respiratory specialist care - a clinical-epidemiological study in Germany. Curr Med Res Opin (2011) 0.80
Avian malaria in African black-footed penguins. J Am Vet Med Assoc (1979) 0.80
Correction of glutathione deficiency in the lower respiratory tract of HIV seropositive individuals by glutathione aerosol treatment. Thorax (1993) 0.80
Cigarette smoking, but not sensitization to Alternaria, is associated with severe asthma in urban patients. J Asthma (2001) 0.80
Dural invasion of meningiomas adjacent to the tumor margin on Gd-DTPA-enhanced MR images: histopathologic correlation. Eur Radiol (1998) 0.80
The whole story: treatment outcomes with Symbicort. Respir Med (2002) 0.79
Randomized, placebo controlled trial of withdrawal of slow-acting antirheumatic drugs and of observer bias in rheumatoid arthritis. Scand J Rheumatol (1996) 0.79
Comparing asthma treatment in elderly versus younger patients. Respir Med (2011) 0.79
Evaluation of segmentation algorithms for generation of patient models in radiofrequency hyperthermia. Phys Med Biol (1998) 0.79
Hemodynamic response to LBNP following 2 hours HDT (-6 degrees). Aviat Space Environ Med (1986) 0.78
Sputum induction leads to a decrease of exhaled nitric oxide unrelated to airflow. Eur Respir J (2003) 0.78
Do barbiturates impair zymosan-induced granulocyte function? J Crit Care (1994) 0.78
Vertebral artery decompression in a patient with rotational occlusion. Acta Neurochir (Wien) (2008) 0.78
[Immunomodulation therapy for allergic asthma. What is already possible, what is to come?]. Dtsch Med Wochenschr (2008) 0.78
Additional NO2 exposure induces a decrease in cytokine specific mRNA expression and cytokine release of particle and fibre exposed human alveolar macrophages. Eur J Med Res (1999) 0.78
Statistical analysis of chronic obstructive pulmonary disease exacerbations in clinical studies: expectations and limitations. J Physiol Pharmacol (2009) 0.78
Intermediate-term clinical and hemodynamic results of the neonatal arterial switch operation for complete transposition of the great arteries. Int J Cardiol (1992) 0.78